In 2023, European countries exhibited a varied turnover per employee in the basic pharmaceutical products and preparations sector. Switzerland led among these with 2.25 million euros per employee, indicating a highly efficient sector. Belgium and Sweden followed, suggesting robust pharmaceutical industries. In contrast, Slovakia recorded the lowest turnover, highlighting growth opportunities. Other large economies like Germany and the UK had moderate figures, suggesting room for productivity enhancements.
Looking forward, key trends to watch include:
- Technological advancements driving efficiency and turnover.
- Impact of regulatory changes within the EU on pharmaceutical productivity.
- Emerging market competition influencing European markets' turnover per employee.
- Sustainability initiatives potentially increasing operational costs and influencing efficiency.
Top countries in Basic Pharmaceutical Products and Pharmaceutical Preparations Turnover Per Employee by Country
| # | 10 Countries | Thousand Euros | Last Year | |
|---|---|---|---|---|
| 1 | 1 Switzerland | 2,250 | 2023 | View data |
| 2 | 2 Belgium | 1,690 | 2023 | View data |
| 3 | 3 Sweden | 1,340 | 2023 | View data |
| 4 | 4 Denmark | 810.4 | 2023 | View data |
| 5 | 5 Iceland | 688.4 | 2023 | View data |
| 6 | 6 Germany | 498.4 | 2023 | View data |
| 7 | 7 Finland | 493.4 | 2023 | View data |
| 8 | 8 Netherlands | 489.9 | 2023 | View data |
| 9 | 9 Italy | 391.9 | 2023 | View data |
| 10 | 10 United Kingdom | 371.2 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...